Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Edwards

Showing results (1161-1170 of 1,259) with videos related to

Pageof 126
Sort By:
Gynecologic Oncology|April 11, 2017
Surgical-pathological findings in type 1 and 2 endometrial cancer: An NRG Oncology/Gynecologic Oncology Group study on GOG-210 protocolWilliam T Creasman, Shamshad Ali, David G Mutch, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|March 16, 2021
Beyond Teenage and Young Adult Cancer Care: Care Experiences of Patients Aged 25-39 Years Old in the UK National Health ServiceE Lidington, A S Darlington, C Vlooswijk, et al.
Gynecologic Oncology|June 6, 2024
Association of allostatic load with overall survival in epithelial ovarian cancerLauren Borho, Riyue Bao, Esther Elishaev, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 21, 2016
The Association of Peripheral Blood Regulatory T-Cell Concentrations With Epithelial Ovarian Cancer: A Brief ReportRikki A Cannioto, Lara E Sucheston-Campbell, Shalaka Hampras, et al.
Bioorganic & Medicinal Chemistry Letters|October 29, 2017
6-Substituted quinolines as RORγt inverse agonistsJ Kent Barbay, Maxwell D Cummings, Marta Abad, et al.
Journal of Medicinal Chemistry|August 5, 2011
Structure based drug design of crizotinib (PF-02341066), a potent and selective dual inhibitor of mesenchymal-epithelial transition factor (c-MET) kinase and anaplastic lymphoma kinase (ALK)J Jean Cui, Michelle Tran-Dubé, Hong Shen, et al.
Ecology Letters|August 6, 2013
Reliable, verifiable and efficient monitoring of biodiversity via metabarcodingYinqiu Ji, Louise Ashton, Scott M Pedley, et al.
Cell Chemical Biology|September 5, 2020
Assessing IRAK4 Functions in ABC DLBCL by IRAK4 Kinase Inhibition and Protein DegradationJing Zhang, Liqiang Fu, Bin Shen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 7, 2022
Effects of the WRITE Symptoms Interventions on Symptoms and Quality of Life Among Patients With Recurrent Ovarian Cancers: An NRG Oncology/GOG Study (GOG-0259)Heidi S Donovan, Susan M Sereika, Lari B Wenzel, et al.
Journal of Medicinal Chemistry|July 19, 2021
Gut-Restricted Selective Cyclooxygenase-2 (COX-2) Inhibitors for Chemoprevention of Colorectal CancerZhuming Zhang, Avijit Ghosh, Peter J Connolly, et al.
Pageof 126

Showing results (1161-1170 of 1,259) with videos related to

Sort By:
Pageof 126
Gynecologic Oncology|April 11, 2017
Surgical-pathological findings in type 1 and 2 endometrial cancer: An NRG Oncology/Gynecologic Oncology Group study on GOG-210 protocolWilliam T Creasman, Shamshad Ali, David G Mutch, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|March 16, 2021
Beyond Teenage and Young Adult Cancer Care: Care Experiences of Patients Aged 25-39 Years Old in the UK National Health ServiceE Lidington, A S Darlington, C Vlooswijk, et al.
Gynecologic Oncology|June 6, 2024
Association of allostatic load with overall survival in epithelial ovarian cancerLauren Borho, Riyue Bao, Esther Elishaev, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 21, 2016
The Association of Peripheral Blood Regulatory T-Cell Concentrations With Epithelial Ovarian Cancer: A Brief ReportRikki A Cannioto, Lara E Sucheston-Campbell, Shalaka Hampras, et al.
Bioorganic & Medicinal Chemistry Letters|October 29, 2017
6-Substituted quinolines as RORγt inverse agonistsJ Kent Barbay, Maxwell D Cummings, Marta Abad, et al.
Journal of Medicinal Chemistry|August 5, 2011
Structure based drug design of crizotinib (PF-02341066), a potent and selective dual inhibitor of mesenchymal-epithelial transition factor (c-MET) kinase and anaplastic lymphoma kinase (ALK)J Jean Cui, Michelle Tran-Dubé, Hong Shen, et al.
Ecology Letters|August 6, 2013
Reliable, verifiable and efficient monitoring of biodiversity via metabarcodingYinqiu Ji, Louise Ashton, Scott M Pedley, et al.
Cell Chemical Biology|September 5, 2020
Assessing IRAK4 Functions in ABC DLBCL by IRAK4 Kinase Inhibition and Protein DegradationJing Zhang, Liqiang Fu, Bin Shen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 7, 2022
Effects of the WRITE Symptoms Interventions on Symptoms and Quality of Life Among Patients With Recurrent Ovarian Cancers: An NRG Oncology/GOG Study (GOG-0259)Heidi S Donovan, Susan M Sereika, Lari B Wenzel, et al.
Journal of Medicinal Chemistry|July 19, 2021
Gut-Restricted Selective Cyclooxygenase-2 (COX-2) Inhibitors for Chemoprevention of Colorectal CancerZhuming Zhang, Avijit Ghosh, Peter J Connolly, et al.
Pageof 126